Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
STAR Protocols|May 27, 2022
Single-cell suspension preparation from murine organs following in vivo mRNA-LNP exposureSonia Ndeupen, Zhen Qin, Botond Z Igyártó
Current Opinion in Virology|April 27, 2021
Future considerations for the mRNA-lipid nanoparticle vaccine platformBotond Z Igyártó, Sonya Jacobsen, Sonia Ndeupen
Iscience|November 29, 2021
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatorySonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatorySonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 responsesSonia Ndeupen, Aurélie Bouteau, Christopher Herbst, et al.
Plos Pathogens|January 24, 2022
Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responsesSonia Ndeupen, Aurélie Bouteau, Christopher Herbst, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Nature Medicine|January 15, 2026
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.
Pageof 1